Table 2 Dose and Frequency of carbamazepine as monotherapy
From: Epilepsy control with carbamazepine monotherapy from a genetic perspective
Variables | Baseline (n = 79) | 3rd months (n = 71) | Dose Titration rate | 6th months (n = 62) | Dose Titration rate |
|---|---|---|---|---|---|
Dose (mg/day) | 455 ± 133 | 479 ± 142 | 24 ± 12.3 | 495 ± 133 | 16 ± 11.5 |
Frequency of dose | |||||
OD, n (%) | 30 (38.0) | 12 (17.0) | 8 (13.0) | ||
DIB, n (%) | 35 (44.3) | 39 (55.0) | 30 (48.3) | ||
TID, n (%) | 14 (17.7) | 20 (28.0) | 24 (38.7) | ||
Carbamazepine C/D Ratio | – | 0.019 ± 0.007 | – | 0.013 ± 0.006 | – |